Jerome Msihid - Sanofi | 人才画像

基本信息

浏览量：3

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 125 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Long-term Safety and Efficacy of Dupilumab in Patients with Uncontrolled, Moderate-to-Severe Asthma Recruited from Korean Centers: A Subgroup Analysis of the Phase 3 LIBERTY ASTHMA TRAVERSE Trial

Chin Kook Rhee,Jung-Won Park,Heung-Woo Park, Hayeon Noh,Jerome Msihid,You Sook Cho

ALLERGY ASTHMA & IMMUNOLOGY RESEARCHno. 4 (2024): 372-386

引用0浏览0WOS引用

Treatment preferences in previously treated patients with haemophilia A: Phase 3 XTEND-1 study of efanesoctocog alfa

E. Spasov,D. Quon, K. Fukutake,J. Msihid,A. Willemze,J. Dumont, H. Palmborg,N. Kragh, A. Wilson

HAEMOPHILIA (2024): 96-96

引用0浏览0引用

OP-059 Lung Function Improvement by Dupilumab Associated with Better Asthma Control in Children

Leonard B Bacharier, Sharon Dell, Inés de Mir,Giorgio Piacentini, Eckard Hamelmann,Jérôme Msihid, Rebecca Gall, Olivier Ledanois, Zhixiao Wang, Wei-Han Cheng,Harry Sacks, Juby A Jacob-Nara, Paul J Rowe, Sena Dericioğlu, Yamo Deniz

Oral Presentation (2024)

引用0浏览0引用

Dupilumab Versus Mepolizumab for Chronic Rhinosinusitis with Nasal Polyposis: an Indirect Treatment Comparison

Claire Hopkins,Joseph K. Han,Wytske Fokkens,Martin Wagenmann,Patricia Guyot,Asif H. Khan,Scott Nash,Zhixiao Wang,Yingxin Xu,Jérôme Msihid, Binod Neupane,Arpita Nag,Claus Bachert

The Journal of Allergy and Clinical Immunology In Practice (2024)

引用0浏览0WOS引用

Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis with Nasal Polyps

Claire Hopkins,Joaquim Mullol,Asif H. Khan,Stella E. Lee,Martin Wagenmann,Peter Hellings,Wytske Fokkens,Jerome Msihid,Radhika Nair,Siddhesh Kamat,Scott Nash,Amr Radwan,Juby A. Jacob-Nara,Yamo Deniz,Paul J. Rowe

OTOLARYNGOLOGY-HEAD AND NECK SURGERYno. 4 (2024): 1173-1182

引用0浏览0WOS引用

53782 Dupilumab Improves Sleep Quality in Patients with Chronic Spontaneous Urticaria Inadequately Controlled with H1 Antihistamines

Gil Yosipovitch, Marcus Maurer, Ana M. Giménez-Arnau,Heike Rockmann-Helmbach, Naoko Inomata, Luis Felipe Ensina, Philip Sugerman,Jerome Msihid,Sonya Cyr,Ryan B. Thomas,Chien-Chia Chuang

Journal of the American Academy of Dermatologyno. 3 (2024): AB33

引用0浏览0引用

53474 Dupilumab Improves Self-Perception and Relationships among Patients with Chronic Spontaneous Urticaria Uncontrolled by H1 Antihistamines

Ana Maria Gimenez-Arnau,Lisa A. Beck,Marcus Maurer, Shunsuke Takahagi, Luis Felipe Ensina, Philip Sugerman,Jerome Msihid,Sonya Cyr,Ryan B. Thomas,Chien-Chia Chuang

Journal of the American Academy of Dermatologyno. 3 (2024): AB187

引用0浏览0引用

Effect of Avalglucosidase Alfa on Disease-Specific and General Patient-Reported Outcomes in Treatment-Naïve Adults with Late-Onset Pompe Disease Compared with Alglucosidase Alfa: Meaningful Change Analyses from the Phase 3 COMET Trial

Antonio Toscano,Laurence Pollissard,Jerome Msihid,Nadine van der Beek,Priya S. Kishnani,Mazen M. Dimachkie,Kenneth I. Berger,Pronabesh Dasmahapatra,Nathan Thibault,Alaa Hamed,Tianyue Zhou,Kristina An Haack,Benedikt Schoser

MOLECULAR GENETICS AND METABOLISMno. 2 (2024)

引用0浏览0WOS引用

PHASE 2 TRIAL OF RILIPRUBART IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: QUALITY-OF-LIFE AND FATIGUE

Pieter A. Van Doorn,Luis Querol,Hans-Peter Hartung, Richard A. C. Hughes, Mattea Orsini, Natalia Hakimi-Hawken, Charles Minor,Jerome Msihid, Miguel Alonso-Alonso, Nazem Atassi, Richard Lewis

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2024): S130-S130

引用0浏览0引用

Efficacy of Frexalimab on Physical and Psychological Impacts and Fatigue in Relapsing Multiple Sclerosis: Findings from MSIS-29v2 and PROMIS-Fatigue-MS-8a Assessments in a Phase 2 Trial (P10-6.001)

Patrick Vermersch,Stephane Saubadu,Philippe Truffinet, Benoit Arnould, Natalia Hakimi-Hawken, Charles Minor,Lita Araujo, Samuel Gourlain,Jerome Msihid,Gavin Giovannoni

Neurology（2024）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn